IIM
CTKB icon

INTECH Investment Management’s Cytek Biosciences CTKB Stock Holding History

INTECH Investment Management’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Sell
25,629
-26,111
-50% -$123K ﹤0.01% 1873
2025
Q4 		$261K Buy
51,740
+3,242
+7% +$15.1K ﹤0.01% 1834
2025
Q3 		$168K Buy
48,498
+1,556
+3% +$5.84K ﹤0.01% 2125
2025
Q2 		$160K Sell
46,942
-20,923
-31% -$69.7K ﹤0.01% 2163
2025
Q1 		$272K Buy
67,865
+18,161
+37% +$94.1K ﹤0.01% 1946
2024
Q4 		$323K Buy
49,704
+26,567
+115% +$158K ﹤0.01% 1801
2024
Q3 		$128K Buy
+23,137
New +$131K ﹤0.01% 1839

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

INTECH Investment Management's CTKB Position: Q1 2026 in Review

INTECH Investment Management reduced its Cytek Biosciences (CTKB) stake by 50% in Q1 2026, selling an estimated $123K and leaving 25,629 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1873.

INTECH Investment Management first reported a position in CTKB in Q3 2024 and has held it in 7 quarters since. The position peaked at $323K in Q4 2024. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • INTECH Investment Management held 25,629 shares of Cytek Biosciences worth $112K as of Q1 2026.
  • INTECH Investment Management sold 26,111 Cytek Biosciences shares in Q1 2026, an estimated $123K.
  • Cytek Biosciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1873 holding.
  • INTECH Investment Management first reported a position in Cytek Biosciences in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Cytek Biosciences position peaked at $323K in Q4 2024.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.